id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0579-0009,FDA,FDA-2013-N-0579,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Biological
Products: Reporting of Biological Product Deviations and Human Cells,
Tissues, and Cellular and Tissue-Based Deviations in Manufacturing",Notice,30 Day Proposed Information Collection,2019-12-26T05:00:00Z,2019,12,2019-12-26T05:00:00Z,2020-01-28T04:59:59Z,2019-12-26T15:03:34Z,2019-27791,0,0,090000648424ffef
FDA-2013-N-0579-0007,FDA,FDA-2013-N-0579,"Agency Information Collection Activities; Proposed Collection;
Comment Request; Biological Products: Reporting of Biological
Product Deviations and Human Cells, Tissues, and Cellular and TissueBased Deviations in Manufacturing",Notice,60 Day Proposed Information Collection,2019-07-31T04:00:00Z,2019,7,2019-07-31T04:00:00Z,2019-10-01T03:59:59Z,2019-12-02T19:43:49Z,2019-16243,0,0,0900006483dd472a